Tuesday, April 15, 2014
Theravance to Report First Quarter 2014 Financial Results on May 6, 2014
Thursday, April 10, 2014
Theravance Announces Initiation of Phase 2b Study With TD-4208, an Investigational LAMA for the Treatment of COPD
Tuesday, April 1, 2014
Theravance Appoints Kevin Kwok, Head of Talent Acquisition and Strategy
Medicines that make a difference®
We apply our multivalency expertise to discover, develop and commercialize small molecule medicines for significant unmet medical needs.
We pursue a best-in-class strategy designed to discover superior medicines across multiple therapeutic areas.
We partner with pharmaceutical companies to accelerate development and commercialization of our product candidates.
Every day at Theravance, we think it through, find a way, and get it done so that together with our partners we can bring patients much needed new medicines.
Theravance discovers, develops and brings important medicines to patients by: